Munich
Germany
20
2025-06-19
The entities that hold a legal rights for patent applications filed by inventor Winderlich Mark:
Mark Winderlich from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
COMBINATIONS AND USES THEREOF
#2 | 2025-06-12TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT
#3 | 2024-12-26COMBINATIONS AND USES THEREOF
#4 | 2024-11-07COMBINATIONS AND USES THEREOF
#5 | 2024-01-11COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF
#6 | 2022-09-08METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
#7 | 2022-03-24Combinations and uses thereof
#8 | 2021-09-23TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT
#9 | 2020-11-12COMBINATIONS AND USES THEREOF
#10 | 2020-11-12COMBINATIONS AND USES THEREOF
#11 | 2020-07-02COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF
#12 | 2019-06-27METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
#13 | 2018-08-16Combinations and uses thereof
#14 | 2018-06-07Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof
#15 | 2018-01-25Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide
#16 | 2016-08-04Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib
#17 | 2015-01-15Combinations and uses thereof
#18 | 2014-09-11COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD
#19 | 2014-08-14Combination therapy with an anti-CD19 antibody and a purine analog
#20 | 2013-11-14Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
528284 ⎘